Community Action Needed: Please respond to the NIH RFI
ZFIN ID: ZDB-PUB-190326-9
The Dietary Flavonoid, Luteolin, Negatively Affects Neuronal Differentiation
Swaminathan, A., Basu, M., Bekri, A., Drapeau, P., Kundu, T.K.
Date: 2019
Source: Frontiers in molecular neuroscience   12: 41 (Journal)
Registered Authors: Drapeau, Pierre, Swaminathan, Amrutha
Keywords: embryonic stem cells, flavonoid, lysine acetyltransferase, neuronal differentiation, p300
MeSH Terms: none
PubMed: 30906251 Full text @ Front. Mol. Neurosci.
Luteolin, a polyphenolic plant flavonoid, has been attributed with numerous beneficial properties like anti-cancer, antioxidant, and anti-inflammatory action. Luteolin has been reported earlier to be neuroprotective in models of spinal cord injury and traumatic brain injury and also induces neurite outgrowth in PC12 cells. However, the effect of luteolin on early differentiation, which might be important for its beneficial effects, is unknown. In this report, we show that luteolin negatively affects early differentiation of embryonic stem cells, hampering the formation of embryoid bodies. At later stages of differentiation, luteolin specifically inhibits neuronal differentiation, where the expression of early neuronal markers is suppressed, whereas luteolin treatment does not inhibit expression of meso- and endodermal markers. Further, in a developing zebrafish model, luteolin treatment leads to fewer numbers of mitotic cells in the brain. These specific effects of luteolin on neuronal differentiation could possibly be due to its ability to inhibit the lysine acetyltransferase, p300, since the structurally closely related p300 non-inhibitor flavonoid, apigenin, does not inhibit neuronal differentiation. These results show that luteolin perturbs neuronal differentiation of embryonic stem cells.